Travers Smith LLP has advised AURELIUS Equity Opportunities ("AURELIUS"), a pan-European alternative investment firm, on its disposal of Briar Chemicals Limited, the UK's leading agrochemical Contract Development and Manufacturing Organisation, to Safex Chemicals India Limited.
Briar Chemicals, based in Norwich, joined the AURELIUS portfolio in 2012, following a corporate carve-out transaction from Bayer CropScience. Following the carve-out, the Norwich site was established as a stand-alone contract manufacturer. Production was comprehensively reorganised to improve operational on-site support, assign responsibility to individual production units for safety, output, and quality across all day-to-day activities.
The Travers Smith team was led by Head of Risk & Operational Regulatory Doug Bryden and Corporate Partner Mohammed Senouci, supported by Senior Counsel John Buttanshaw, Senior Associate Laura Smyth and Associates Alexandra MacBean and Jonathan Fritz. Tax advice was provided by Head of Tax Russell Warren and Senior Associate Sivanti Dvakumar.
Bird & Bird provided legal advice to Safex Chemicals India Limited on the transaction.
